Annual balance sheet for Mustang Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 110 | 75.7 | 6.23 | 6.84 | 17.3 |
| Net Total Receivables | 0.05 | 0.036 | 3.88 | 0.402 | 0.217 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 112 | 78.9 | 11.3 | 8.61 | 17.6 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 12.1 | 12.3 | 4.81 | 0.452 | 0 |
| Other Long Term Assets | |||||
| Total Assets | 125 | 92.4 | 17.7 | 9.31 | 17.6 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 10.8 | 15.1 | 15.4 | 12.6 | 7.91 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 12.8 | 46.1 | 17.6 | 13.2 | 8.06 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 112 | 46.3 | 0.123 | -3.87 | 9.53 |
| Total Liabilities & Shareholders' Equity | 125 | 92.4 | 17.7 | 9.31 | 17.6 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |